**Moscow, Russia October 10, 2017** – **InSysBio LLC**, one of the pioneers in Quantitative Systems Pharmacology (QSP) modeling and simulation for the drug development, announced a renewal of the corporate identity.
>“Lately we have become more successful and have grown bigger. We are expanding our business and are attracting new customers and partners. And now we need to become more vivid and recognizable. That is why rebranding of the company is a logical step”, Oleg Demin Jr, the head of Business Development, spoke about the reasons for such changes.
>“The official name InSysBio is now short and memorable. A new symbol is a cell made of gear-wheels. It shows that we consider the living organism and its processes as parts of the mechanism that is accurately described in our models and platforms. Corporate colors are just the employees’ favorite colors. It's so important to surround yourself with what you like and do what you love”, Oleg explained the meanings of attributes of the corporate identity.
You can meet the new InSysBio in a week at the eighth American Conference on Pharmacometrics (ACoP8), to be held from October 15th to October 18th, 2017. The meeting will take place at the Marriott Resort: Harbor Beach Hotel, Fort Lauderdale, Florida.
See InSysBio ACoP8 [Agenda here](http://insilicobio.ru/share/ACoP8_agenda.pdf). Don’t miss our exhibition **booth #4**.
| ← | October 2018 | → | ||||
| Mo | Tu | We | Th | Fr | Sa | Su |
|---|---|---|---|---|---|---|
|
1
1.
01 Oct 2018 12:23
InSysBio Announces Continuation of Collaboration with MedImmune for Quantitative Systems Pharmacology Modeling in Systemic Lupus Erythematosus
InSysBio, a pioneer in Quantitative Systems Pharmacology (QSP), modeling and simulation for drug development, announced today an extension of a collaboration with MedImmune, the global biologics research and development arm of AstraZeneca, for QSP modeling in systemic lupus erythematosus (SLE). The goal is to support the clinical development of anifrolumab, an investigational monoclonal antibody against the type I interferon receptor, by modeling the contributions of key cell types involved in the pathophysiology of lupus that are associated with the type I interferon dysregulation commonly seen with the disease.
|
2
1.
02 Oct 2018 14:05
InSysBio to present at ACoP9
InSysBio announces their participation at Ninth American Conference on Pharmacometrics (ACoP9), to be held October 7th to 10th, 2018, at the Loews Coronado Bay Resort near San Diego, CA. The theme of ACoP9 is “Modeling without Bounds”. InSysBio welcomes visitors at the booth #23.
|
3
|
4
|
5
|
6
|
7
|
|
8
|
9
1.
09 Oct 2018 15:29
InSysBio starts training course “Modeling for systems biology and biomedicine”
InSysBio expert modelers Dr. Galina Lebedeva, Dr. Tatiana Karelina, Dr. Evgeny Metelkin and Dr. Oleg Demin will give the course “Modeling for systems biology and biomedicine” at the Faculty of bioengineering and bioinformatics, Lomonosov Moscow State University.
|
10
|
11
|
12
|
13
|
14
|
|
15
|
16
|
17
|
18
|
19
1.
19 Oct 2018 15:49
InSysBio to present at BiotechClub 2018
InSysBio announces their participation at BiotechClub 2018 conference to be held on October 26th at Hyatt Regency Moscow Petrovsky Park. The theme of BiotechClub 2018 is “From Systems Biology to Systems Medicine”.
|
20
|
21
|
|
22
|
23
|
24
1.
24 Oct 2018 13:49
InSysBio to present at ICSB 2018
InSysBio announces their participation at 19th International Conference on Systems Biology (ICSB 2018) to be held October 28th to November 1st, 2018 in Lyon, France.
|
25
|
26
|
27
|
28
|
|
29
|
30
|
31
| ||||